While β-ARs have been the primary focus of adrenergic-targeted cancer research, recent studies suggest that alpha-adrenergic receptors (α-ARs), particularly the α1 subtype, may also play a role in modulating tumor biology. This evidence concerns the gene AARS1 and neoplasm.